BAG-1 Promotes Apoptosis Induced by N-(4-hydroxyphenyl)retinamide in Human Cervical Carcinoma Cells
- 1 May 2000
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 256 (2) , 491-499
- https://doi.org/10.1006/excr.2000.4829
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Retinoids in the chemoprevention of bladder cancerCurrent Opinion in Oncology, 1998
- Interaction of BAG-1 with Retinoic Acid Receptor and Its Inhibition of Retinoic Acid-induced Apoptosis in Cancer CellsJournal of Biological Chemistry, 1998
- Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expressionThe Prostate, 1997
- Phase II Chemoprevention Trial of Oral Fenretinide in Patients at Risk for Adenocarcinoma of the ProstateAmerican Journal of Clinical Oncology, 1997
- Retinoids and Apoptosis: Implications for Cancer Chemoprevention and TherapyJNCI Journal of the National Cancer Institute, 1995
- Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2Blood, 1995
- Strategy and planning for chemopreventive drug development: Clinical development plansJournal of Cellular Biochemistry, 1994
- Breast cancer chemopreventionEuropean Journal Of Cancer, 1993
- Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Chemoprevention of experimental carcinogenesis in animalsPreventive Medicine, 1989